Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

A government crackdown on cheaper copies of Ozempic and similar diabetes and weight-loss drugs was intended to shut the door on that booming market. It hasn’t exactly worked out that way.

Where would you say Ozempic ranks in terms of ... which also opened the way for knockoff versions of the drugs to further erode Novo's market share. Jorgensen eventually resolved the manufacturing ...

News last week that a CNN investigative report found dozens of fake podcasts on the popular audio streaming and media service platform Spotify, illegally ...

Novo Nordisk reduced its starter dose prices through telehealth platforms to encourage patients to wean themselves off compounded copycats.

Lars Rebien Sørensen, who chairs the Novo Nordisk Foundation, will join its board as an observer while the company seeks a ...

Dow Jones Top Company Headlines at 11 PM ET: GM Is Pushing Hard to Tank California’s EV Mandate | Trump ... The Senate will vote as early as next week on a measure to revoke the state's emissions ...

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have shed half their ...

Science-Backed PhenQ Supplement Offers a Natural, Multi-Action Alternative to GLP-1 Drugs Like Ozempic-Empowering 2025 Weight ...